Mortality and causes of death in older patients with schizophrenia

International Journal of Geriatric Psychiatry

Volumn 27, Issue 11, 2012, Pages 1131-1137

  Talaslahti, Tiina ^a   Alanen, Hanna Mari ^b   Hakko, Helinä ^c   Isohanni, Matti ^d   Häkkinen, Unto ^e   Leinonen, Esa ^b,f  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

causes of death; mortality; older patients; schizophrenia; Standard Mortality Ratio (SMR)

Indexed keywords

ACCIDENT; AGED; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; CONTROLLED STUDY; DEMENTIA; DISEASE REGISTRY; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GERIATRIC PATIENT; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; ICD-10; ICD-8; ICD-9; INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; MORTALITY; NEOPLASM; NEUROLOGIC DISEASE; RELAPSE; REMISSION; RESPIRATORY TRACT DISEASE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STANDARDIZED MORTALITY RATIO; SUICIDE; UROGENITAL TRACT DISEASE; VASCULAR DISEASE; VIOLENCE;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEMALE; FINLAND; HUMANS; MALE; SCHIZOPHRENIA; SEX DISTRIBUTION;

EID: 84867336726     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2833     Document Type: Article

References (37)

1. Alaräisänen A, Miettunen J, Räsänen P, et al,. 2009. Suicide rate in schizophrenia in the Northern Finland 1966 birth cohort. Soc Psychiatry Psychiatr Epidemiol 44 (12): 1107-1110.
2. Aro S, Koskinen R, Keskimäki I,. 1990. Reliability of hospital discharge data concerning diagnosis, treatments and accidents. Duodecim 106 (21): 1443-1450.
3. Bazin N,. 2004. Suicide and depression in the elderly. Psychol Neuropsychiatr Vieil 2: S29-S33.
4. Breslow NE, Day NE,. 1987. Statistical methods in cancer research. Volume II-the design and analysis of cohort studies. IARC Sci Publ 82: 1-406.
5. Brown S, Kim M, Mitchell C, Inskip H,. 2010. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 196 (2): 116-121.
6. Bushe CJ, Bradley AJ, Wildgust HJ, Hodgson RE,. 2009. Schizophrenia and breast cancer incidence: a systematic review of clinical studies. Schizophr Res 114 (1-3): 6-16.
7. Chang CK, Hayes RD, Broadbent M, et al,. 2010. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry 10: 77.
8. Cohen CI, Vahia I, Reyes P, et al,. 2008. Focus on geriatric psychiatry: schizophrenia in later life: clinical symptoms and social well-being. Psychiatr Serv 59 (3): 232-234.
9. Copeland LA, Zeber JE, Rosenheck RA, Miller AL,. 2006. Unforeseen inpatient mortality among veterans with schizophrenia. Med Care 44 (2): 110-116.
10. De Hert MA, van Winkel R, Van Eyck D, et al,. 2006. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res 83 (1): 87-93.
11. Druss BG, Bradford WD, Rosenheck RA, et al,. 2001. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry 58 (6): 565-572.
12. Hartikainen S, Lönnroos E, Louhivuori K,. 2007. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 62 (10): 1172-1181.
13. Hor K, Taylor M,. 2010. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol 24 (4): S81-S90.
14. Isohanni M, Mäkikyrö T, Moring J, et al,. 1997. A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia. Soc Psychiatry Psychiatr Epidemiol 32 (5): 303-308.
15. Jeste DV,. 2004. Tardive dyskinesia rates with atypical antipsychotics in older adults. J Clin Psychiatry 65 (9): S21-S24.
16. Joukamaa M, Heliövaara M, Knekt P, et al,. 2001. Mental disorders and cause-specific mortality. Br J Psychiatry 179: 498-502.
17. Karvonen K, Räsänen P, Hakko H, et al,. 2008. Suicide after hospitalization in the elderly: a population based study of suicides in Northern Finland between 1988-2003. Int J Geriatr Psychiatry 23 (2): 135-141.
18. Kiviniemi M, Suvisaari J, Pirkola S, et al,. 2010. Regional differences in five-year mortality after a first episode of schizophrenia in Finland. Psychiatr Serv 61 (3): 272-279.
19. Lahti RA, Penttilä A,. 2001. The validity of death certificates: routine validation of death certification and its effects on mortality statistics. Forensic Sci Int 115 (1-2): 15-32.
20. Laursen TM, Munk-Olsen T, Agerbo E, et al,. 2009. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry 66 (7): 713-720.
21. Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB,. 2007. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 68 (6): 899-907.
22. Lavsa SM, Fabian TJ, Saul MI, et al,. 2010. Influence of medications and diagnoses on fall risk in psychiatric inpatients. Am J Health Syst Pharm 67 (15): 1274-1280.
23. Leucht S, Burkard T, Henderson J, et al,. 2007. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 116 (5): 317-333.
24. Limosin F, Loze JY, Philippe A, et al,. 2007. Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr Res 94 (1-3): 23-28.
25. Miettunen J, Suvisaari J, Haukka J, Isohanni M,. 2011. Use of register data for psychiatric epidemiology in the Nordic countries. In Textbook in Psychiatric Epidemiology, 3rd edition, Tsuang M, Tohen M, Jones P, (eds.) John Wiley & Sons: Chichester, West Sussex; 117-131.
26. Moilanen K, Veijola J, Läksy K, et al,. 2003. Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 birth cohort. Soc Psychiatry Psychiatr Epidemiol 38 (6): 305-310.
27. Mortensen PB, Juel K,. 1993. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 163: 183-189.
28. Osborn D, Levy G, Nazareth I, King M,. 2008. Suicide and severe mental illnesses. Cohort study within the UK general practice research database. Schizophr Res 99 (1-3): 134-138.
29. Osby U, Correia N, Brandt L, et al,. 2000. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 45 (1-2): 21-28.
30. Palmer BA, Pankratz VS, Bostwick JM,. 2005. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 62 (3): 247-253.
31. Räsänen S, Hakko H, Viilo, K, et al,. 2003. Excess mortality among long-stay psychiatric patients in Northern Finland. Soc Psychiatry Psychiatr Epidemiol 38 (6): 297-304.
32. Saha S, Chant D, McGrath J,. 2007. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64 (10): 1123-1131.
33. Schoos R, Cohen CI,. 2003a. Medical comorbidity in older persons with schizophrenia. In Schizophrenia into Later Life, Cohen CI, (ed.). American Psychiatric Publishing: Washington, London; 113-138.
34. Schoos R, Cohen CI,. 2003b. Medical comorbidity in older persons with schizophrenia. In Schizophrenia into Later Life, Cohen CI, (ed.). American Psychiatric Publishing: Washington, London; 113-138.
35. Suvisaari JM, Saarni SI, Perälä J, et al,. 2007. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry 68 (7): 1045-1055.
36. Tiihonen J, Lönnqvist J, Wahlbeck K, et al,. 2009. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 374 (9690): 620-627.
37. Wildgust HJ, Beary M,. 2010. Are there modifiable risk factors which will reduce the excess mortality in schizophrenia? J Psychopharmacol Suppl 24 (4): 37-50.